Last reviewed · How we verify

Lacosamide - rapid titration 1 — Competitive Intelligence Brief

Lacosamide - rapid titration 1 (Lacosamide - rapid titration 1) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiepileptic agent (sodium channel modulator). Area: Neurology.

marketed Antiepileptic agent (sodium channel modulator) Voltage-gated sodium channels (slow inactivation enhancer) Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Lacosamide - rapid titration 1 (Lacosamide - rapid titration 1) — Seoul National University Hospital. Lacosamide enhances slow inactivation of voltage-gated sodium channels, thereby stabilizing neuronal membranes and reducing seizure activity.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Lacosamide - rapid titration 1 TARGET Lacosamide - rapid titration 1 Seoul National University Hospital marketed Antiepileptic agent (sodium channel modulator) Voltage-gated sodium channels (slow inactivation enhancer)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiepileptic agent (sodium channel modulator) class)

  1. Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lacosamide - rapid titration 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/lacosamide-rapid-titration-1. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: